IQVIA HOLDINGS INC. (IQV)
Industrials › Services-Commercial Physical & Biological Research
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 120% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 17.4% — good return on equity
- Revenue growing at 6% annually
IQVIA HOLDINGS INC. (IQV) is a Industrials company operating in Services-Commercial Physical & Biological Research, listed on the NYSE , with a market capitalisation of $28.3 billion . Key value metrics: P/E ratio 25.1, P/B ratio 4.36, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
IQVIA HOLDINGS INC. — Fundamental Analysis Summary
IQVIA HOLDINGS INC. (IQV) is currently trading 120% above its Graham Number of $75.81, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 25.1x.
On financial health, IQV shows a moderate Piotroski F-Score of 5/9, and solid return on equity of 17.4% (sector average: 5.5%), and high leverage with a debt-to-equity ratio of 2.14.
StockPik's composite Value Score for IQV is 42/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
IQV shows revenue growing at 6% year-over-year, with earnings declining at 1%.